Lumeda is a medical technology company advancing photodynamic therapy (PDT) to treat NSCLC and other thoracic malignancies. The company applies advanced photonics and proprietary artificial intelligence software to automate and digitize PDT light delivery. Its technology aims to improve physician control, reduce procedure time and enable data capture for treatment planning. Lumeda's multidisciplinary team has decades of experience in the photonics industry with expertise in systems engineering and commercialization of new technology. The company announced the closing of a $4.3M Series A, bringing total funding to date to $5.3M. Lumeda is based in Rocky Hill, CT.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2021